Cargando…

A Novel Polymeric Nanohybrid Antimicrobial Engineered by Antimicrobial Peptide MccJ25 and Chitosan Nanoparticles Exerts Strong Antibacterial and Anti-Inflammatory Activities

Infection caused by antibiotic-resistant microorganisms (ARMs) has been declared a global threat to public health. Polymeric nanoparticles (PNPs) formed by antimicrobial peptides (AMPs) and synthetic PNPs against ARM infections are emerging. PNPs are also considered to be a promising natural biologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Haitao, Yu, Yifan, Chen, Mingchao, Sun, Shuaijuan, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807516/
https://www.ncbi.nlm.nih.gov/pubmed/35126369
http://dx.doi.org/10.3389/fimmu.2021.811381
_version_ 1784643691095261184
author Haitao, Yu
Yifan, Chen
Mingchao, Sun
Shuaijuan, Han
author_facet Haitao, Yu
Yifan, Chen
Mingchao, Sun
Shuaijuan, Han
author_sort Haitao, Yu
collection PubMed
description Infection caused by antibiotic-resistant microorganisms (ARMs) has been declared a global threat to public health. Polymeric nanoparticles (PNPs) formed by antimicrobial peptides (AMPs) and synthetic PNPs against ARM infections are emerging. PNPs are also considered to be a promising natural biological preservative that prevents microbial spoilage through food processing and preservation. We engineered CNMs, a novel nanocomposite antibacterial agent based on chitosan nanoparticles and AMP microcin J25. In this study, we aimed to evaluate the comprehensive antimicrobial activity, potential antimicrobial mechanism, and anti-inflammatory activity of CNMs. We demonstrated that CNMs harbor excellent bactericidal activity against clinical foodborne pathogens and ARMs. CNMs caused fast mortality against different growth phases of tetracycline (Tet)-resistant enterotoxigenic E. coli (ETEC) and significantly killed Tet-resistant ETEC in food biological environments. Mechanistically, CNMs have the ability to bind lipopolysaccharides (LPS), neutralize endotoxin, and promote diaphragm permeability by damaging the cell membrane. CNMs did not cause mouse RAW264.7 cell cytotoxicity. Notably, CNMs significantly reduced the cytotoxicity of RAW264.7 macrophages induced by LPS. The LPS-induced inflammatory response was significantly ameliorated by CNMs by reducing the levels of nitric oxide and proinflammatory cytokines, including tumor necrosis factor α, interleukin (IL)-6, IL-8, IL-1β, Toll-like receptor 4, and nuclear factor κB (NF-κB), in LPS-challenged RAW264.7 macrophages. CNMs downregulated the NF-κB and mitogen-activated protein kinase signaling pathways, thereby inhibiting inflammatory responses upon LPS stimulation. Taken together, CNMs could be applied as effective antimicrobial/anti-inflammatory agents with lower cytotoxicity in food, medicine, and agriculture to prevent bacterial contamination and infection, respectively.
format Online
Article
Text
id pubmed-8807516
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88075162022-02-03 A Novel Polymeric Nanohybrid Antimicrobial Engineered by Antimicrobial Peptide MccJ25 and Chitosan Nanoparticles Exerts Strong Antibacterial and Anti-Inflammatory Activities Haitao, Yu Yifan, Chen Mingchao, Sun Shuaijuan, Han Front Immunol Immunology Infection caused by antibiotic-resistant microorganisms (ARMs) has been declared a global threat to public health. Polymeric nanoparticles (PNPs) formed by antimicrobial peptides (AMPs) and synthetic PNPs against ARM infections are emerging. PNPs are also considered to be a promising natural biological preservative that prevents microbial spoilage through food processing and preservation. We engineered CNMs, a novel nanocomposite antibacterial agent based on chitosan nanoparticles and AMP microcin J25. In this study, we aimed to evaluate the comprehensive antimicrobial activity, potential antimicrobial mechanism, and anti-inflammatory activity of CNMs. We demonstrated that CNMs harbor excellent bactericidal activity against clinical foodborne pathogens and ARMs. CNMs caused fast mortality against different growth phases of tetracycline (Tet)-resistant enterotoxigenic E. coli (ETEC) and significantly killed Tet-resistant ETEC in food biological environments. Mechanistically, CNMs have the ability to bind lipopolysaccharides (LPS), neutralize endotoxin, and promote diaphragm permeability by damaging the cell membrane. CNMs did not cause mouse RAW264.7 cell cytotoxicity. Notably, CNMs significantly reduced the cytotoxicity of RAW264.7 macrophages induced by LPS. The LPS-induced inflammatory response was significantly ameliorated by CNMs by reducing the levels of nitric oxide and proinflammatory cytokines, including tumor necrosis factor α, interleukin (IL)-6, IL-8, IL-1β, Toll-like receptor 4, and nuclear factor κB (NF-κB), in LPS-challenged RAW264.7 macrophages. CNMs downregulated the NF-κB and mitogen-activated protein kinase signaling pathways, thereby inhibiting inflammatory responses upon LPS stimulation. Taken together, CNMs could be applied as effective antimicrobial/anti-inflammatory agents with lower cytotoxicity in food, medicine, and agriculture to prevent bacterial contamination and infection, respectively. Frontiers Media S.A. 2022-01-19 /pmc/articles/PMC8807516/ /pubmed/35126369 http://dx.doi.org/10.3389/fimmu.2021.811381 Text en Copyright © 2022 Haitao, Yifan, Mingchao and Shuaijuan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Haitao, Yu
Yifan, Chen
Mingchao, Sun
Shuaijuan, Han
A Novel Polymeric Nanohybrid Antimicrobial Engineered by Antimicrobial Peptide MccJ25 and Chitosan Nanoparticles Exerts Strong Antibacterial and Anti-Inflammatory Activities
title A Novel Polymeric Nanohybrid Antimicrobial Engineered by Antimicrobial Peptide MccJ25 and Chitosan Nanoparticles Exerts Strong Antibacterial and Anti-Inflammatory Activities
title_full A Novel Polymeric Nanohybrid Antimicrobial Engineered by Antimicrobial Peptide MccJ25 and Chitosan Nanoparticles Exerts Strong Antibacterial and Anti-Inflammatory Activities
title_fullStr A Novel Polymeric Nanohybrid Antimicrobial Engineered by Antimicrobial Peptide MccJ25 and Chitosan Nanoparticles Exerts Strong Antibacterial and Anti-Inflammatory Activities
title_full_unstemmed A Novel Polymeric Nanohybrid Antimicrobial Engineered by Antimicrobial Peptide MccJ25 and Chitosan Nanoparticles Exerts Strong Antibacterial and Anti-Inflammatory Activities
title_short A Novel Polymeric Nanohybrid Antimicrobial Engineered by Antimicrobial Peptide MccJ25 and Chitosan Nanoparticles Exerts Strong Antibacterial and Anti-Inflammatory Activities
title_sort novel polymeric nanohybrid antimicrobial engineered by antimicrobial peptide mccj25 and chitosan nanoparticles exerts strong antibacterial and anti-inflammatory activities
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807516/
https://www.ncbi.nlm.nih.gov/pubmed/35126369
http://dx.doi.org/10.3389/fimmu.2021.811381
work_keys_str_mv AT haitaoyu anovelpolymericnanohybridantimicrobialengineeredbyantimicrobialpeptidemccj25andchitosannanoparticlesexertsstrongantibacterialandantiinflammatoryactivities
AT yifanchen anovelpolymericnanohybridantimicrobialengineeredbyantimicrobialpeptidemccj25andchitosannanoparticlesexertsstrongantibacterialandantiinflammatoryactivities
AT mingchaosun anovelpolymericnanohybridantimicrobialengineeredbyantimicrobialpeptidemccj25andchitosannanoparticlesexertsstrongantibacterialandantiinflammatoryactivities
AT shuaijuanhan anovelpolymericnanohybridantimicrobialengineeredbyantimicrobialpeptidemccj25andchitosannanoparticlesexertsstrongantibacterialandantiinflammatoryactivities
AT haitaoyu novelpolymericnanohybridantimicrobialengineeredbyantimicrobialpeptidemccj25andchitosannanoparticlesexertsstrongantibacterialandantiinflammatoryactivities
AT yifanchen novelpolymericnanohybridantimicrobialengineeredbyantimicrobialpeptidemccj25andchitosannanoparticlesexertsstrongantibacterialandantiinflammatoryactivities
AT mingchaosun novelpolymericnanohybridantimicrobialengineeredbyantimicrobialpeptidemccj25andchitosannanoparticlesexertsstrongantibacterialandantiinflammatoryactivities
AT shuaijuanhan novelpolymericnanohybridantimicrobialengineeredbyantimicrobialpeptidemccj25andchitosannanoparticlesexertsstrongantibacterialandantiinflammatoryactivities